Thermo Fisher Scientific Explores Anti-cancer Therapeutic for Gene Therapy

Share Article

In this webinar, which LabRoots will host September 28, attendees will gain a better comprehension of anti-cancer gene therapies by understanding cytokine-induced programmed cell death.

Leah Persaud PhD Candidate; Lehman College, City University of New York; The Graduate Center, City University of New York

The use of gene therapy is well studied due to its potential to treat cancer, the second leading cause of death worldwide. The goal of gene therapy is to introduce functional genetic material into human cells to be transcribed and translated in order to regulate, repair or suppress a molecular mechanism that contributes to a disease state.

Compared to traditional cancer therapies such as surgery, chemotherapy or radiation therapy, gene therapy is a more personalized and targeted approach because it is based on understanding the genetic profile of a patient’s tumor. The cytokine Interleukin-24 (IL-24), is of special interest for gene therapy because of its selective killing effect on numerous cancer cell types while having no effect on corresponding normal cells.

In this webinar, participants will learn how IL-24 treatment kills cancer cells and ultimately better understand how cell lines are used to decipher molecular signaling pathways for the development of anti-cancer therapeutics.

For this event, Thermo Fisher Scientific has arranged for Leah Persaud, a doctoral candidate at the Lehman College, City University of New York, to be the speaker.

Persaud completed her undergraduate degrees in biology and forensic science from the University of New Haven in Connecticut. As an undergraduate, she performed research on highly specific DNA nucleases for gene therapy at Justus Liebig University in Giessen, Germany. Currently, she is a doctoral candidate at the City University of New York Graduate Center, working in Dr. Moira Sauane's cancer research lab at Lehman College.

LabRoots will host the event September 28, 2017, beginning at 10:00 a.m. PDT. To read more about this event, discover what continuing education credits will be offered, or to register for free, click here.

About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of $18 billion and more than 55,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive support. For more information, please visit http://www.thermofisher.com.

About LabRoots
LabRoots is the leading scientific social networking website, which provides daily scientific trending news, as well as produces educational virtual events and webinars, on the latest discoveries and advancements in science. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning, and is a primary source for current scientific news, webinars, virtual conferences, and more. LabRoots has grown into the world’s largest series of virtual events within the Life Sciences and Clinical Diagnostics community.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Karen Sorenson
LabRoots, Inc.
+1 (619) 861-0590
Email >
Visit website